SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

-----------------

 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

(Amendment No. )1

 

eXegenics Inc.

------------------------------------------------------------------------------

(Name of Issuer)

 

Common Stock, $.01 par value

------------------------------------------------------------------------------

 

(Title of Class of Securities)

 

301610 10 1

------------------------------------------------------------------------------

(CUSIP Number)

 

March 27, 2007

-----------------------------------------------------------------------------

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which

this Schedule is filed:

 

o Rule 13d-1(b)

 

x Rule 13d-1(c)

 

 

o Rule 13d-1(d)

_________________________

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

CUSIP No. 301610 10 1

Page 2 of 6 Pages

 

 

________________________________

1. NAMES OF REPORTING PERSONS

 

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

 

Johnson & Johnson

22-1024240

________________________________

2.

CHECK THE APPROPRIATE BOX IF

(a) o

 

A MEMBER OF A GROUP

(b) o

________________________________

3.

SEC USE ONLY

________________________________

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

New Jersey

________________________________

 

NUMBER OF

5.

SOLE VOTING POWER

 

SHARES

 

BENEFICIALLY

-0-

 

OWNED BY

 

EACH

6.

SHARED VOTING POWER

 

REPORTING

PERSON WITH

16,125,775 shares of Common Stock

 

 

7.

SOLE DISPOSITIVE POWER

 

 

-0-

 

 

8.

SHARED DISPOSITIVE POWER

 

16,125,775 shares of Common Stock

________________________________

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

16,125,775 shares of Common Stock

________________________________

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o

________________________________

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

 

12.5%

________________________________

12.

TYPE OF REPORTING PERSON

 

 

CO

________________________________

The numbers set forth above include shares of Common Stock issuable upon conversion of Series C Preferred Stock and exercise of presently-exercisable stock options and warrants to purchase Common Stock.

 

 

-2-

CUSIP No. 301610 10 1

Page 3 of 6 Pages

 

 

________________________________

1. NAMES OF REPORTING PERSONS

 

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Johnson & Johnson Development Corporation

22-2007137

________________________________

 

2.

CHECK THE APPROPRIATE BOX IF

(a) o

 

A MEMBER OF A GROUP

(b) o

________________________________

3.

SEC USE ONLY

________________________________

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

New Jersey

________________________________

 

NUMBER OF

5.

SOLE VOTING POWER

 

SHARES

 

BENEFICIALLY

-0-

 

OWNED BY

 

EACH

6.

SHARED VOTING POWER

 

REPORTING

 

PERSON WITH

16,125,775 shares of Common Stock

 

 

7.

SOLE DISPOSITIVE POWER

 

 

-0-

 

 

8.

SHARED DISPOSITIVE POWER

 

16,125,775 shares of Common Stock

________________________________

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

16,125,775 shares of Common Stock

________________________________

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES o

________________________________

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

 

12.5%

________________________________

12.

TYPE OF REPORTING PERSON

 

 

CO

________________________________

The numbers set forth above include shares of Common Stock issuable upon conversion of Series C Preferred Stock and exercise of presently-exercisable stock options and warrants to purchase Common Stock.

 

 

-3-

CUSIP No. 301610 10 1

Page 4 of 6 Pages

 

 

Schedule 13G

 

ITEM 1(a) -

NAME OF ISSUER:

 

eXegenics Inc.

 

ITEM 1(b) -

ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:

 

1250 Pittsford-Victor Road

Pittsford, NY 14534

 

ITEM 2(a) -

NAME OF PERSON FILING:

 

This statement is being filed by Johnson & Johnson, a New Jersey corporation (“J&J”), and Johnson & Johnson Development Corporation, a New Jersey corporation (“JJDC”). JJDC is a wholly-owned subsidiary of J&J. The securities reported herein as being held by J&J and JJDC are directly beneficially owned by JJDC. J&J may be deemed to indirectly beneficially own the securities that are directly beneficially owned by JJDC.

 

ITEM 2(b) -

ADDRESS OF PRINCIPAL BUSINESS OFFICE:

 

One Johnson & Johnson Plaza

New Brunswick, NJ 08933

 

ITEM 2(c) -

CITIZENSHIP:

 

J&J: New Jersey

JJDC: New Jersey

 

ITEM 2(d) -

TITLE OF CLASS OF SECURITIES:

 

Common Stock, $.01 par value per share (“Common Stock”)

 

ITEM 2(e) -

CUSIP NUMBER:

 

301610 10 1

 

ITEM 3 -

STATEMENTS FILED PURSUANT TO RULES 13D-1(B) OR

13D-2(B) OR (C):

 

Not applicable.

 

ITEM 4 -

OWNERSHIP:

 

The numbers set forth below include shares of Common Stock issuable upon conversion of Series C Preferred Stock and exercise of presently-exercisable stock options and warrants to purchase Common Stock.

 

(a) Amount Beneficially Owned:

 

J&J: 16,125,775 shares of Common Stock

JJDC: 16,125,775 shares of Common Stock

 

(b) Percent of Class:

 

 

-4-

CUSIP No. 301610 10 1

Page 5 of 6 Pages

 

 

J&J: 12.5%

JJDC: 12.5%

 

(c) Number of shares as to which such person has:

 

 

(i) sole power to vote or to direct the vote: -0-

 

 

(ii) shared power to vote or to direct the vote:

 

J&J: 16,125,775 shares of Common Stock

JJDC: 16,125,775 shares of Common Stock

 

(iii) sole power to dispose or to direct the disposition of: -0-

 

(iv) shared power to dispose or to direct the disposition of:

 

J&J: 16,125,775 shares of Common Stock

JJDC: 16,125,775 shares of Common Stock

 

ITEM 5 -

OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

 

Not applicable.

 

ITEM 6 -

OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:

 

Not applicable.

 

ITEM 7 -

IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY:

 

Not applicable.

 

ITEM 8 -

IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:

 

Not applicable.

 

ITEM 9 -

NOTICE OF DISSOLUTION OF GROUP:

 

Not applicable.

 

ITEM 10 -

CERTIFICATION:

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

-5-

CUSIP No. 301610 10 1

Page 6 of 6 Pages

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

 

JOHNSON & JOHNSON

 

 

By

/s/ DOUGLAS CHIA

 

Name: Douglas Chia

 

Title: Assistant Secretary

 

 

JOHNSON & JOHNSON DEVELOPMENT CORPORATION

 

 

By

/s/ JAYNE ZALL

 

Name: Jayne Zall

 

Title: Secretary

 

 

Dated: April 6, 2007

 

 

-6-